6-methylpurine (6mp) is a toxic analog of adenine that inhibits RNA and protein synthesis and interferes with adenine salvage mediated by adenine phosphoribosyltransferase (APRTase). Mutants of the ciliated protist that are resistant to 6mp were isolated in 1974, but the mechanism of resistance has remained unknown. To investigate 6mp resistance in , we created 6mp-resistant strains and identified a mutation in the APRTase genomic locus () that is responsible for 6mp resistance. While overexpression of the mutated allele in 6mp-sensitive cells did not confer resistance to 6mp, reduced wild-type expression resulted in a significant decrease in sensitivity to 6mp. Knocking out or reducing the expression of by RNA interference (RNAi) did not affect robust cell growth, which indicates that adenine salvage is redundant or that de novo synthesis pathways provide sufficient adenosine monophosphate for viability. We also explored whether 6mp resistance could be used as a novel inducible selection marker by generating 6mp- and paromomycin-resistant double mutants. While 6mp- and paromomycin-resistant double mutants did express fluorescent proteins in an RNAi-based system, the system requires optimization before 6mp resistance can be used as an effective inducible selection marker.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924521PMC
http://dx.doi.org/10.3390/genes9040179DOI Listing

Publication Analysis

Top Keywords

6mp resistance
16
adenine phosphoribosyltransferase
8
6mp
8
adenine salvage
8
inducible selection
8
selection marker
8
6mp- paromomycin-resistant
8
paromomycin-resistant double
8
double mutants
8
resistance
7

Similar Publications

Epidermal growth factor receptor wild type lung adenocarcinoma (EGFR LUAD) still has limited treatment options and unsatisfactory clinical outcomes. Ferroptosis, as a form of cell death, has been reported to play a dual role in regulating tumor cell survival. In this study, we constructed a 3-ferroptosis-gene signature, FeSig, and verified its accuracy and efficacy in predicting EGFR LUAD prognosis at both the RNA and protein levels.

View Article and Find Full Text PDF

Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia.

Front Oncol

July 2024

Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States.

Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with relapse being a major obstacle to successful treatment. Our understanding of the mechanisms driving chemotherapy resistance and ultimately relapse in leukemia remains incomplete. Herein, we investigate the impact of the tumor microenvironment on leukemia cell drug responses using human plasma-like media (HPLM), designed to mimic physiological conditions more accurately .

View Article and Find Full Text PDF

Relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) is a major cause of pediatric cancer-related deaths. Relapse-specific mutations do not account for all chemotherapy failures in B- ALL patients, suggesting additional mechanisms of resistance. By mining RNA-seq datasets of paired diagnostic/relapse pediatric B-ALL samples, we discovered pervasive alternative splicing (AS) patterns linked to relapse and affecting drivers of resistance to glucocorticoids, anti-folates, and thiopurines.

View Article and Find Full Text PDF
Article Synopsis
  • * The study investigates the relationship between chemoresistance in B-ALL and histidine metabolism, revealing that histidine supplementation can improve responsiveness to the standard chemotherapy drug, 6-mercaptopurine (6-MP).
  • * It highlights the importance of desuccinylation by the enzyme SIRT5 as a crucial factor in enhancing the effectiveness of histidine therapy, offering a new strategy to combat chemoresistance and improve survival rates in young B-ALL patients.
View Article and Find Full Text PDF

The role of ABCC4, an ATP-binding cassette transporter, in the process of platelet formation, megakaryopoiesis, is unknown. Here, we show that ABCC4 is highly expressed in megakaryocytes (MKs). Mining of public genomic data (ATAC-seq and genome wide chromatin interactions, Hi-C) revealed that key megakaryopoiesis transcription factors (TFs) interacted with ABCC4 regulatory elements and likely accounted for high ABCC4 expression in MKs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!